In this region, The Asia-Pacific injectable drug delivery market is projected to reach USD 143,089.37 million by 2024, from USD 56,198.43 million in 2016 growing at a CAGR of 12.4% in the forecast period 2017 to 2024.
Based on geography, the Asia-Pacific injectable drug delivery market is segmented into 11 geographical regions, such as,
Japan,

China,
South Korea,
India,
Australia,
Singapore,
Thailand,
Malaysia,
Indonesia,
Philippines and
Rest Of Asia-Pacific.
Asia-Pacific injectable drug delivery market competition by top players including -
Some of the major players operating in this market are
Baxter International, Inc.,
Becton Dickinson and Company,
Gerresheimer AG, Pfizer, Inc.,
Schott AG, Alkermes Plc.,
Eli Lilly and Company,
Sandoz,
Terumo Corporation,
Teva Pharmaceuticals Industries Ltd.,
Ypsomed,
Bespak.

The Asia-Pacific injectable drug delivery market is segmented on the basis of type, product type, application, usage pattern, mode of administration, end user, distribution channel, and geography.
The Asia-Pacific injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices.
The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.
On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others.
The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn?s disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anaemia, osteoporosis and others.
On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.
On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.
On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others.
On the basis of distribution channel, the market is classified into hospital pharmacies, pharmacy store, direct tender, and online pharmacy.